Literature DB >> 33567267

A suite of new Dre recombinase drivers markedly expands the ability to perform intersectional genetic targeting.

Ximeng Han1, Zhenqian Zhang2, Lingjuan He2, Huan Zhu2, Yan Li2, Wenjuan Pu2, Maoying Han3, Huan Zhao2, Kuo Liu4, Yi Li5, Xiuzhen Huang2, Mingjun Zhang2, Hengwei Jin2, Zan Lv2, Juan Tang2, Jinjin Wang6, Ruilin Sun6, Jian Fei6, Xueying Tian7, Shengzhong Duan8, Qing-Dong Wang9, Lixin Wang10, Ben He11, Bin Zhou12.   

Abstract

The use of the dual recombinase-mediated intersectional genetic approach involving Cre-loxP and Dre-rox has significantly enhanced the precision of in vivo lineage tracing, as well as gene manipulation. However, this approach is limited by the small number of Dre recombinase driver constructs available. Here, we developed more than 70 new intersectional drivers to better target diverse cell lineages. To highlight their applicability, we used these new tools to study the in vivo adipogenic fate of perivascular progenitors, which revealed that PDGFRa+ but not PDGFRa-PDGFRb+ perivascular cells are the endogenous progenitors of adult adipocytes. In addition to lineage tracing, we used members of this new suite of drivers to more specifically knock out genes in complex tissues, such as white adipocytes and lymphatic vessels, that heretofore cannot be selectively targeted by conventional Cre drivers alone. In summary, these new transgenic tools expand the intersectional genetic approach while enhancing its precision.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cre-loxP; Dre-rox; adipocyte progenitors; fate mapping; intersectional genetics; lineage tracing; lymphatic endothelial cells; white adipocytes

Year:  2021        PMID: 33567267     DOI: 10.1016/j.stem.2021.01.007

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  25 in total

Review 1.  CRISPR in cancer biology and therapy.

Authors:  Alyna Katti; Bianca J Diaz; Christina M Caragine; Neville E Sanjana; Lukas E Dow
Journal:  Nat Rev Cancer       Date:  2022-02-22       Impact factor: 60.716

Review 2.  Crosstalk Between Adipose and Lymphatics in Health and Disease.

Authors:  Gregory P Westcott; Evan D Rosen
Journal:  Endocrinology       Date:  2022-01-01       Impact factor: 4.736

Review 3.  Clinical and therapeutic relevance of cancer-associated fibroblasts.

Authors:  Yang Chen; Kathleen M McAndrews; Raghu Kalluri
Journal:  Nat Rev Clin Oncol       Date:  2021-09-06       Impact factor: 66.675

Review 4.  Insights into skeletal stem cells.

Authors:  Qiwen Li; Ruoshi Xu; Kexin Lei; Quan Yuan
Journal:  Bone Res       Date:  2022-10-19       Impact factor: 13.362

Review 5.  Recent advances in lineage tracing for the kidney.

Authors:  Yoshiharu Muto; Benjamin D Humphreys
Journal:  Kidney Int       Date:  2021-07-01       Impact factor: 10.612

Review 6.  Mechanisms and cell lineages in lymphatic vascular development.

Authors:  Daniyal J Jafree; David A Long; Peter J Scambler; Christiana Ruhrberg
Journal:  Angiogenesis       Date:  2021-04-06       Impact factor: 9.596

7.  Cardiovascular diseases disrupt the bone-marrow niche.

Authors:  Tomer Itkin; Shahin Rafii
Journal:  Nature       Date:  2022-01       Impact factor: 49.962

Review 8.  Mouse models of vascular development and disease.

Authors:  Ondine Cleaver
Journal:  Curr Opin Hematol       Date:  2021-05-01       Impact factor: 3.218

Review 9.  Prostate cancer cell heterogeneity and plasticity: Insights from studies of genetically-engineered mouse models.

Authors:  Weiping Li; Michael M Shen
Journal:  Semin Cancer Biol       Date:  2021-06-18       Impact factor: 17.012

Review 10.  Modeling metastasis in mice: a closer look.

Authors:  Arianna Giacobbe; Cory Abate-Shen
Journal:  Trends Cancer       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.